SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novo Nordisk reports quarterly results through September 30

A machine-generated LSEG earnings summary covers the quarter ended September 30.

NOVOB
SquawkNews Desk

FORECAST CHANGESRECOMMENDATIONSThis summary was machine generated from LSEG data November 4 at 06:09 p.m. UTC. ​All figures in Danish crowns unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com.

For any other questions or feedback, contact R…

Related stories

Upstart Raises Fee Outlook but Cuts 2026 Revenue and EBITDA Forecasts Upstart reported Q3 2026 revenue of $370.5 million, up 34% year over year, and earnings of 66 cents per share. It lowered 2026 revenue guidance to approximately $1.35 billion from M impact | EQUITY | Nov 04, 2026, 07:04 PM UTC NNN REIT Reports Higher Q3 Earnings, Revenue and FFO Third-quarter 2026 net earnings were $0.57 per diluted share versus $0.51 a year earlier. Core FFO and AFFO per diluted share increased 5.9% and 5.8% to $0.90 and $0.91, respective M impact | EQUITY | Nov 04, 2026, 07:03 PM UTC Skyworks Forecasts Q1 Revenue of $1.8B-$1.9B, Below Estimates Skyworks also guided for adjusted earnings of $1.25 per share, below the $1.57 consensus estimate. It expects Android business to decline by more than 20% in the December quarter, M impact | EQUITY | Nov 04, 2026, 07:03 PM UTC Coupang Revenue Rises 7% to $9.96 Billion in Q3 Coupang reported a $0.28 per-share loss, including about $248 million in costs tied to a July fire at a leased Incheon fulfillment center; excluding the fire impact, the loss was $ M impact | EQUITY | Nov 04, 2026, 07:03 PM UTC Sanofi Ends Autoimmune Disease Drug Program Nurix says Sanofi is ending its program related to drugs for autoimmune diseases. L impact | EQUITY | Nov 04, 2026, 07:01 PM UTC Expeditors Reports Third-Quarter Revenue of $4.11 Billion, EPS of $2.65 Revenue rose 41.9% year over year to $4.11 billion, net income attributable to shareholders increased 55% to $344.5 million, and diluted EPS climbed 61.6% to $2.65. M impact | EQUITY | Nov 04, 2026, 07:01 PM UTC